| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |